[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PH19066A - Composition and method of use of anticholinergic drugs - Google Patents

Composition and method of use of anticholinergic drugs

Info

Publication number
PH19066A
PH19066A PH26453A PH26453A PH19066A PH 19066 A PH19066 A PH 19066A PH 26453 A PH26453 A PH 26453A PH 26453 A PH26453 A PH 26453A PH 19066 A PH19066 A PH 19066A
Authority
PH
Philippines
Prior art keywords
composition
anticholinergic drugs
anticholinergic
drugs
Prior art date
Application number
PH26453A
Inventor
Peter Bieck
John William Fara
Johan Urquhart
Jane Elizabeth Shaw
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of PH19066A publication Critical patent/PH19066A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH26453A 1980-11-12 1981-11-06 Composition and method of use of anticholinergic drugs PH19066A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH839180 1980-11-12

Publications (1)

Publication Number Publication Date
PH19066A true PH19066A (en) 1985-12-17

Family

ID=4339605

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26453A PH19066A (en) 1980-11-12 1981-11-06 Composition and method of use of anticholinergic drugs

Country Status (13)

Country Link
EP (1) EP0052074B1 (en)
JP (1) JPS57114508A (en)
BE (1) BE891069A (en)
CY (1) CY1457A (en)
DE (2) DE3175894D1 (en)
GB (1) GB2087234B (en)
HK (1) HK4889A (en)
IT (1) IT1172052B (en)
MY (1) MY8700681A (en)
NL (1) NL8104929A (en)
NZ (1) NZ198942A (en)
PH (1) PH19066A (en)
ZA (1) ZA817796B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105990B (en) * 1981-08-27 1985-06-19 Nitto Electric Ind Co Adhesive skin patches
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
EP0198034B1 (en) * 1984-10-11 1991-06-12 Key Pharmaceuticals, Inc. Physiological means of enhancing transdermal delivery of drugs
US4707495A (en) * 1985-10-28 1987-11-17 Ortho Pharmaceutical Peptic ulcer treatment method
AU3512595A (en) * 1994-09-13 1996-03-29 Magainin Pharmaceuticals, Inc. Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
JP2001267000A (en) 2000-03-21 2001-09-28 Sumitomo Wiring Syst Ltd Water-proofconnector
JO3510B1 (en) * 2011-03-04 2020-07-05 Heptares Therapeutics Ltd Use of glycopyrrolate for treating tachycardia
JP6073231B2 (en) * 2011-08-31 2017-02-01 興和株式会社 Stable pharmaceutical composition
JP2017014292A (en) * 2016-10-24 2017-01-19 ロート製薬株式会社 Pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally

Also Published As

Publication number Publication date
EP0052074A2 (en) 1982-05-19
EP0052074A3 (en) 1983-04-13
HK4889A (en) 1989-01-27
IT1172052B (en) 1987-06-18
NL8104929A (en) 1982-06-01
DE3144504A1 (en) 1982-06-24
GB2087234B (en) 1986-06-25
MY8700681A (en) 1987-12-31
IT8149667A0 (en) 1981-11-10
DE3175894D1 (en) 1987-03-12
JPH0150683B2 (en) 1989-10-31
BE891069A (en) 1982-05-10
ZA817796B (en) 1982-10-27
CY1457A (en) 1989-07-21
GB2087234A (en) 1982-05-26
NZ198942A (en) 1991-04-26
EP0052074B1 (en) 1987-02-04
JPS57114508A (en) 1982-07-16

Similar Documents

Publication Publication Date Title
GB2088364B (en) Derivatives of nortropane and granatane
PH17019A (en) 4-piperidyl-or dehydropiperidyl-urea derivatives and method of use
JPS5777616A (en) Medicinal composition and manufacture
ZA824233B (en) Therapeutic method and method for making compositions for use therein
ZA806534B (en) Injectabel catheter and method of placing same
PT72914B (en) Beta-lactam compounds their preparation and use
DE3363472D1 (en) Process for the preparation of n-substituted n-cyano-amides and their use
PH15907A (en) Novel naphthyridine derivatives and method of use thereof
PH18772A (en) Nalbuphine-narcotic analgesic composition and method of producing anlgesia
ZA822487B (en) Analgetic compositions and methods of use
EP0108147A4 (en) Use of a protoberberine alkaloid and composition containing same.
PH19066A (en) Composition and method of use of anticholinergic drugs
PH19352A (en) Fluoromethylthiooxacephalosporins derivatives compositions containing same and method of use thereof
GB2042463B (en) Container and method of manufacture
GB2080809B (en) Phenoxyisobutyrates of moroxydin and drugs containing them
PH16943A (en) Anticoccidial formulation and method of use thereof
DE3272452D1 (en) Medicinal composition and method of making same
JPS56139481A (en) Quinoline derivative and medicinal composition containing same
DE3162049D1 (en) Method for the preparation of 2-halo-3-sulfonyl-acrylonitriles and their use
GB2079273B (en) Preparation of 1-hydropentadecafluoro-adamantane and perfluoroadamantane
PH22247A (en) Diazepinoindole, pharmaceutical composition and method of use thereof
JPS56104884A (en) Substituted benzopyranotriazoles* their manufacture and medicinal composition containing them
GB2134525B (en) Preparation of olean-12-ene-3b 30-diol and esters thereof
PT71146A (en) Method and composition for preparation of h-sar-lys-sar-gln-nh2
JPS5758646A (en) Alpha-halogenation of methyl-aromatics and alpha-halogenation mixture